Noting that only 25 percent of incidental emboli are identified in reporting of initial computed tomography (CT) exams, Avicenna.AI said the artificial intelligence (AI)-enabled CINA-iPE is geared toward detecting incidental pulmonary embolism (PE) on chest CT scans.
Avicenna.AI has launched CINA-iPE, an artificial intelligence (AI)-powered modality, which may facilitate the diagnosis of incidental pulmonary embolism (PE) on chest computed tomography (CT) examinations.
The company noted that CINA-iPE, which utilizes AI to analyze chest CT scans for incidental PE, is the first modality for CINA Incidental, a new suite of imaging tools geared toward enhancing CT diagnosis of unsuspected pathologies.
While incidental PE is frequently detected on chest CT, Avicenna.AI emphasized that incidental PE is a significant cause of mortality among patients with cancer and maintained that incidental emboli are commonly missed in reporting for initial CT assessments.
“Pulmonary embolism is a dangerous, life-threatening condition and with CINA-iPE, we hope to increase the number of patients identified with incidental PE and help improve their outcomes,” noted Cyril Di Grandi, cofounder and chief executive officer of Avicenna.AI.
Avicenna.AI said it will debut CINA-iPE at the European Congress of Radiology March 1-5, 2023 in Vienna, Austria.
(Editor’s note: For related content, see “Viz.ai Launches AI-Powered Vascular Imaging Software” and “PE Triage Platform from RapidAI Receives FDA 510(k) Clearance.”)
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.